Word

APTAMIR

Status

Pending

Status Code

641

Status Date

Friday, January 5, 2024

Serial Number

97880127

Mark Type

3000

Filing Date

Monday, April 10, 2023

Trademark Owner History

AptamiR Therapeutics, Inc

Classifications

5 Medicinal and biological preparations for pharmaceutical, clinical or medical treatment, namely, preparations for the modulation of gene and protein expression working at DNA transcription, RNA translation and/or degradation processes related thereto for the treatment of cardiovascular diseases, metabolic diseases, overweight, obesity, diabetes mellitus, dyslipidemia, liver steatosis (fatty liver disease), steatohepatitis, non-alcoholic fatty liver disease, metabolic-associated fatty liver disease, atherosclerosis, chronic visceral inflammation, ovarian cancer and related diseases and disorders

The mark consists of the word "APTAMIR" with the first letter "A" in black, the letters "PTA" and "I" in blue, the letter "M" in blue and black, with a blue triangle above, but touching, the letter "M", and the letter "R" in black. The color white represents background and is not a feature of the mark.
The color(s) black and blue is/are claimed as a feature of the mark.

Trademark Events

Apr 5, 2024

Application Extension Granted/Receipt Provided

Apr 5, 2024

Application Extension To Response Period - Received

Jan 5, 2024

Notification Of Non-Final Action E-Mailed

Jan 5, 2024

Non-Final Action E-Mailed

Jan 5, 2024

Non-Final Action Written

Jan 5, 2024

Assigned To Examiner

May 4, 2023

Notice Of Design Search Code E-Mailed

May 3, 2023

New Application Office Supplied Data Entered

Apr 13, 2023

New Application Entered